Friday, the FDA approved GSK plc's (NYSE: GSK) Ojjaara (momelotinib) for intermediate or high-risk myelofibrosis, including primary myelofibrosis or secondary myelofibrosis (post-polycythemia vera and post-essential thrombocythaemia), in
Avinger Inc (NASDAQ: AVGR) shares are trading higher after the company announced the full commercial launch of its Tigereye ST next-generation image-guided chronic total occlusion (CTO) crossing system.
Friday morning, the Committee for Medicinal Products for Human Use of the European Medicines Agency gave a negative opinion on the conversion of the conditional marketing authorization to full marketing authorization of PTC Therapeutics Inc's (NASDAQ: PTCT) Translarna (ataluren) for nonsense m
Thursday, the FDA extended the review period for Iovance Biotherapeutics Inc's (NASDAQ: IOVA) marketing application seeking accelerated approval for lifileucel
Apple Inc (NASDAQ: AAPL) has appointed Tim Millet, a seasoned executive with a background in iPhone and Mac chip technology, to oversee its secretive team dedicated to developing a noninvasive blood sugar monitor, signaling a significant move in the company's health technology endeavors.